 | Actinium Pharmaceuticals, Inc. | |||
| ASE : ATNM || Location: United States | ||||
$6.56-0.5 (-7.08%) |
0.33 M | 6.47 - 6.97 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 1.977 M |
| March 28, 2024 | 2.187 M |
| March 15, 2024 | 1.823 M |
| Feb. 29, 2024 | 1.804 M |
| Feb. 15, 2024 | 1.863 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.55 | -0.34 | 38.27% |
| 09/30/2023 | -0.54 | -0.49 | 9.64% |
| 06/30/2023 | -0.49 | -0.58 | -18.46% |
| 03/31/2023 | -0.43 | -0.43 | 0.42% |
| 12/31/2022 | -0.36 | -0.43 | -18.75% |
ATNM Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 29.396M | Shares Float | 28.609M |
| Short Float | 1.977M | Market Cap | 207.54M |
| Institution ownership | 24.62% | Insider ownership | 2.162% |
| Earnings Date | 05/15/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.83 | Forward EPS | -0.11 |